1982P Post hoc analysis of outcomes according to prior chemotherapy (CT) response and platinum agent in the international SAUL study of atezolizumab (atezo) for urinary tract carcinoma (UTC)
| Autor: | Perez Valderrama, B., Garcia Del Muro, X., Merseburger, A.S., Loriot, Y., Choy, E., Castellano Gauna, D.E., Lopez-Rios, F., Bonfill Abella, T., Montesa Pino, A., Yu, P., Skamnioti, P., Sternberg, C.N. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S1146-S1147 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|